SCHEDULE: Dr. Ronnie Hershman Boosts Nasus Pharma Stake to 15.3%

Dr. Ronnie Hershman and Hershman Holdings LLC reported a combined beneficial ownership of 15.3% in Nasus Pharma Ltd. as of September 30, 2025.

Summary

• Dr. Ronnie Hershman beneficially owns an aggregate of 1,383,512 Ordinary Shares of Nasus Pharma Ltd., representing 15.3% of the class.
• This ownership includes 891,187 Ordinary Shares held by Hershman Holdings LLC, over which Dr. Hershman has sole voting and investment power.
• Additionally, Dr. Hershman's beneficial ownership includes 429,307 Ordinary Shares held by Phoenix Solutions Ltd., where he is the controlling shareholder and may be deemed to share voting and investment power.
• Dr. Hershman also holds 63,018 Ordinary Shares issuable upon the exercise of share options exercisable within 60 days.
• Hershman Holdings LLC separately reported beneficial ownership of 891,187 Ordinary Shares, representing 9.9% of the class, with Dr. Hershman as its managing member having sole voting and dispositive power.
• The percentages are based on 9,014,105 ordinary shares outstanding as of September 30, 2025, as advised by the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant beneficial ownership stake by a key individual and an associated entity, which is generally viewed as a positive sign of insider confidence and alignment with shareholder interests.

Positives

• Significant insider ownership by Dr. Ronnie Hershman (15.3%) indicates strong confidence in the company's future prospects.
• Hershman Holdings LLC, controlled by Dr. Hershman, holds a substantial 9.9% stake, further aligning management interests with shareholders.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Increased insider ownership, particularly by a key individual like Dr. Ronnie Hershman, can be viewed positively by the market as it often signals strong belief in the company's strategy and potential, differentiating it from companies with less insider alignment.

Related Party Transactions

• Dr. Ronnie Hershman is the managing member of Hershman Holdings LLC, which holds 891,187 Ordinary Shares.
• Dr. Ronnie Hershman is the controlling shareholder of Phoenix Solutions Ltd., which holds 429,307 Ordinary Shares.

Stakeholder Impact

• Shareholders may view the significant insider ownership as a positive indicator of management's commitment and belief in the company's long-term value, potentially increasing investor confidence.

Key Dates

Keywords

Nasus Pharma, Beneficial Ownership, Schedule 13G, Insider Ownership, Dr. Ronnie Hershman, Hershman Holdings LLC, Ordinary Shares, Equity Stake